Literature DB >> 21212061

Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation.

Jennifer Worch1, Jobin Cyrus, Robert Goldsby, Katherine K Matthay, John Neuhaus, Steven G DuBois.   

Abstract

BACKGROUND: The incidence of Ewing sarcoma varies by race, with very low rates among persons of African and East Asian ancestry. The incidence by race of other mesenchymal tumors that also harbor EWSR1 translocations has not been studied.
METHODS: The SEER database was queried to find cases of mesenchymal tumors associated with EWSR1 translocations: Ewing sarcoma; clear cell sarcoma; extraskeletal myxoid chondrosarcoma; myxoid liposarcoma; desmoplastic small round cell tumor; and myoepithelial tumor. Age-adjusted incidence rates were calculated for white, African American, and Asian/Native American populations and compared statistically.
RESULTS: Ewing sarcoma was significantly less common in the African American and Asian/Native American populations compared with the white population, with incidence rate ratios of 0.12 (95% CI, 0.08-0.20; P<0.001) and 0.54 (95% CI, 0.41-0.69; P<0.001), respectively. Desmoplastic small round cell tumor was significantly more common in the African American population compared with the white population (incidence rate ratio=3.0; 95% CI, 1.62-5.49; P<0.001). Myxoid liposarcoma was significantly less common in the Asian/Native American population compared with the white population (incidence rate ratio=0.72; 95% CI, 0.56-0.92; P=0.006). The incidence rates for extraskeletal myxoid chondrosarcoma, myoepithelial tumors, and clear cell sarcoma did not differ significantly by race.
CONCLUSIONS: Tumors associated with EWSR1 translocation are not uniformly more common in people of European ancestry. IMPACT: The relationship between race and EWSR1 somatic translocation is complex. Future studies investigating the genetic epidemiology of EWSR1 translocated tumors are required. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212061      PMCID: PMC3051020          DOI: 10.1158/1055-9965.EPI-10-1170

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  22 in total

Review 1.  The surveillance, epidemiology, and end results program: a national resource.

Authors:  B F Hankey; L A Ries; B K Edwards
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

2.  Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Authors:  C R Antonescu; S J Tschernyavsky; R Decuseara; D H Leung; J M Woodruff; M F Brennan; J A Bridge; J R Neff; J R Goldblum; M Ladanyi
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

3.  EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.

Authors:  Cristina R Antonescu; Lei Zhang; Ning-En Chang; Bruce R Pawel; William Travis; Nora Katabi; Morris Edelman; Andrew E Rosenberg; G Petur Nielsen; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

4.  Comparative frequency of bone sarcomas among different racial groups.

Authors:  W Guo; W Xu; A G Huvos; J H Healey; C Feng
Journal:  Chin Med J (Engl)       Date:  1999-12       Impact factor: 2.628

5.  Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.

Authors:  C R Antonescu; A Elahi; J H Healey; M F Brennan; M Y Lui; J Lewis; S C Jhanwar; J M Woodruff; M Ladanyi
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

6.  Ethnic and racial differences in patients with Ewing sarcoma.

Authors:  Jennifer Worch; Katherine K Matthay; John Neuhaus; Robert Goldsby; Steven G DuBois
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

Review 7.  Soft tissue tumors associated with EWSR1 translocation.

Authors:  Salvatore Romeo; Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

8.  EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.

Authors:  Sabrina Rossi; Kàroly Szuhai; Marije Ijszenga; Hans J Tanke; Lucia Zanatta; Raf Sciot; Christopher D M Fletcher; Angelo P Dei Tos; Pancras C W Hogendoorn
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

9.  Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.

Authors:  Masanori Hisaoka; Tsuyoshi Ishida; Tseng-Tong Kuo; Atsuji Matsuyama; Tetsuo Imamura; Kazunori Nishida; Hiroshi Kuroda; Yoshiaki Inayama; Hisashi Oshiro; Hiroshi Kobayashi; Takashi Nakajima; Toshio Fukuda; Keisuke Ae; Hiroshi Hashimoto
Journal:  Am J Surg Pathol       Date:  2008-03       Impact factor: 6.394

10.  Utility of FISH in the diagnosis of angiomatoid fibrous histiocytoma: a series of 18 cases.

Authors:  Munir R Tanas; Brian P Rubin; Elizabeth A Montgomery; Sondra L Turner; James R Cook; Raymond R Tubbs; Steven D Billings; John R Goldblum
Journal:  Mod Pathol       Date:  2009-10-02       Impact factor: 7.842

View more
  19 in total

Review 1.  Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets.

Authors:  Stephen L Lessnick; Marc Ladanyi
Journal:  Annu Rev Pathol       Date:  2011-09-19       Impact factor: 23.472

Review 2.  [Functional genomics of Ewing sarcoma].

Authors:  T G P Grünewald
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

3.  Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.

Authors:  Jeremy M Sharib; Jobin Cyrus; Andrew Horvai; Florette K Gray Hazard; John Neuhaus; Katherine K Matthay; Robert Goldsby; Neyssa Marina; Steven G DuBois
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

Review 4.  Germline Variation and Somatic Alterations in Ewing Sarcoma.

Authors:  Mitchell J Machiela; Thomas G P Grünewald
Journal:  Methods Mol Biol       Date:  2021

5.  Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.

Authors:  Thomas G P Grünewald; Virginie Bernard; Pascale Gilardi-Hebenstreit; Virginie Raynal; Didier Surdez; Marie-Ming Aynaud; Olivier Mirabeau; Florencia Cidre-Aranaz; Franck Tirode; Sakina Zaidi; Gaëlle Perot; Anneliene H Jonker; Carlo Lucchesi; Marie-Cécile Le Deley; Odile Oberlin; Perrine Marec-Bérard; Amélie S Véron; Stephanie Reynaud; Eve Lapouble; Valentina Boeva; Thomas Rio Frio; Javier Alonso; Smita Bhatia; Gaëlle Pierron; Geraldine Cancel-Tassin; Olivier Cussenot; David G Cox; Lindsay M Morton; Mitchell J Machiela; Stephen J Chanock; Patrick Charnay; Olivier Delattre
Journal:  Nat Genet       Date:  2015-07-27       Impact factor: 38.330

6.  Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma.

Authors:  Sophie Postel-Vinay; Amélie S Véron; Franck Tirode; Gaelle Pierron; Stéphanie Reynaud; Heinrich Kovar; Odile Oberlin; Eve Lapouble; Stelly Ballet; Carlo Lucchesi; Udo Kontny; Anna González-Neira; Piero Picci; Javier Alonso; Ana Patino-Garcia; Brigitte Bressac de Paillerets; Karine Laud; Christian Dina; Philippe Froguel; Françoise Clavel-Chapelon; Francois Doz; Jean Michon; Stephen J Chanock; Gilles Thomas; David G Cox; Olivier Delattre
Journal:  Nat Genet       Date:  2012-02-12       Impact factor: 38.330

7.  Comparative international incidence of Ewing sarcoma 1988 to 2012.

Authors:  Logan G Spector; Aubrey K Hubbard; Brandon J Diessner; Mitchell J Machiela; Beau R Webber; Joshua D Schiffman
Journal:  Int J Cancer       Date:  2021-05-17       Impact factor: 7.316

Review 8.  Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes.

Authors:  Laurens G L Sand; Karoly Szuhai; Pancras C W Hogendoorn
Journal:  Int J Mol Sci       Date:  2015-07-16       Impact factor: 5.923

9.  Racial and Ethnic Differences in Sarcoma Incidence Are Independent of Census-Tract Socioeconomic Status.

Authors:  Brandon J Diessner; Brenda J Weigel; Paari Murugan; Lin Zhang; Jenny N Poynter; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-14       Impact factor: 4.254

10.  Trabectedin for desmoplastic small round cell tumours: a possible treatment option?

Authors:  Anna Maria Frezza; Jeremy S Whelan; Palma Dileo
Journal:  Clin Sarcoma Res       Date:  2014-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.